Menu
New Jersey Immunization Network
Our Mission Statement

The mission of the New Jersey Immunization Network is to protect the health of all individuals through timely, age-appropriate immunization against vaccine-preventable diseases by educating the public, healthcare professionals, and policymakers about vaccine safety and benefits.

  • About NJIN
    • Meeting Schedule
    • Leadership & Staff
    • Committees
    • Join NJIN
  • Infant and Child
  • Adolescents
    • HPV Roundtable
  • Adults
  • Education
    • HPV Roundtable
  • Resources
    • HPV Roundtable
  • Membership
  • Contact Us
Close Menu
fluvaccine_PD_edited
July 29 2020

No Association Between Influenza Vaccine Exposure in Utero and Adverse Childhood Health Outcomes

immunizenjadmin Featured, Resources - Adult

1. In a systematic review, in utero exposure to influenza vaccine was not associated with adverse health outcomes in children older than 6 months of age.

2. All-cause morbidity and mortality, infectious, autoimmune, atopic, and neurodevelopmental outcomes were examined in the study, which included data from over 750,000 children.

Evidence Rating Level: 2 (Good)

Study Rundown: Influenza while seemingly common, is a respiratory infection that can be life threatening, particularly in young children and pregnant women. Influenza vaccination of pregnant women has been shown to reduce the risk of serious illness in infants during the first 6 months of life. However, skepticism of adverse effects of the vaccine has led to low rates of immunization amongst pregnant women. This study is the first systematic review to assess long term health outcomes in children who were exposed to maternal influenza vaccine in utero. Studies that examined health outcomes of children between age 6 months and 5 years were included in the review, encompassing hundreds of thousands of children. No statistically significant association was found between in utero exposure to influenza vaccine and all cause morbidity and mortality as well as a number of infectious, autoimmune, and neurodevelopmental outcomes. Meta-analyses were not possible due to the small number of studies available. Generalization of the results is limited by the fact that most studies examined exposure to pandemic (not seasonal) influenza vaccines, and all of them were conducted in high income countries in North America or Europe. Nonetheless, the results provide further evidence that maternal immunization with influenza vaccine is unlikely to cause adverse childhood health outcomes and can confidently be recommended to pregnant women.

Click here to continue reading.

Preparing K-12 School Administrators for a Safe Return to School in Fall 2020 Kids Plus AAV Toolkit – Shots Heard Round The World

Related Posts

pcp

Featured

PCPs Continue to Struggle

vaccines

Anti Vaxx, Featured

US Government Slow to Act as Anti-Vaxxers Spread Lies on Social Media About Coronavirus Vaccine

Anti-Vaxx COVID

Anti Vaxx, Featured

Youtube gives Del Bigtree the boot about 4 years too late

Recent Posts

  • PCPs Continue to Struggle
  • US Government Slow to Act as Anti-Vaxxers Spread Lies on Social Media About Coronavirus Vaccine
  • Youtube gives Del Bigtree the boot about 4 years too late
  • Kids Plus AAV Toolkit – Shots Heard Round The World
  • No Association Between Influenza Vaccine Exposure in Utero and Adverse Childhood Health Outcomes

Categories

  • Adolescent Immunization
  • Anti Vaxx
  • Are Vaccines Safe?
  • Diseases and Vaccines
  • Featured
  • For Clinicians
  • For Patients
  • News and Highlights (Adolescents)
  • News and Highlights (Adult Immunization)
  • News and Highlights (Infant and Child)
  • Recommended Adult Vaccines
  • Resources
  • Resources – Adult
  • Webinar
  • Why Immunize?
Back To Top
New Jersey Immunization Network
© 2020 New Jersey Immunization Coaltion
Site by Double Dog Communications

New Jersey Immunization Network
50 Millstone Road
Building 200, Suite 130
East Windsor, New Jersey 08520

Phone: 609-842-0014
Fax: 609-842-0015

Connect With Us

  • Join NJIN
  • Twitter
  • Facebook
  • Email